SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-15-019691
Filing Date
2015-11-05
Accepted
2015-11-05 08:34:35
Documents
19
Period of Report
2015-11-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vbiv20151104_8k.htm 8-K 38594
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 10846
3 a17.jpg GRAPHIC 94397
4 a16.jpg GRAPHIC 212523
5 a15.jpg GRAPHIC 207303
6 a14.jpg GRAPHIC 162124
7 a13.jpg GRAPHIC 132941
8 a12.jpg GRAPHIC 156511
9 a11.jpg GRAPHIC 196268
10 a10.jpg GRAPHIC 132204
11 a9.jpg GRAPHIC 180935
12 a8.jpg GRAPHIC 144750
13 a7.jpg GRAPHIC 125052
14 a6.jpg GRAPHIC 141488
15 a5.jpg GRAPHIC 56737
16 a4.jpg GRAPHIC 285513
17 a3.jpg GRAPHIC 174735
18 a2.jpg GRAPHIC 272563
19 a1.jpg GRAPHIC 82412
  Complete submission text file 0001437749-15-019691.txt   3851318
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 6178303031
VBI VACCINES INC. (Filer) CIK: 0000704159 (see all company filings)

IRS No.: 930589534 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-18188 | Film No.: 151198964
SIC: 2836 Biological Products, (No Diagnostic Substances)